Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Radiotherapy and Oncology
Journal
Overview
Identifiers
View All
Overview
publication venue for
Quantifying risk of radiation necrosis: Normal tissue complication probability modeling following stereotactic radiosurgery for small brain metastases in the modern era
. 214.
2026
Importance of 3D-TSE imaging for patients with brain metastasis treated with SRS alone
. 213.
2025
2024 A representative pattern for radiation-induced cerebral contrast enhancements post intensity modulated proton therapy treatment
. 206:s688-s689.
2025
235 Clinical Impact of Integrating 3D-TSE Imaging into Stereotactic Radiosurgery for Brain Metastases in the Post-Whole Brain Radiotherapy Setting
. 206:s647-s648.
2025
2775 Estimating Radiation Necrosis Risk following Single-fraction Stereotactic Radiosurgery in the Modern Era: An In-Depth Dose-Volume Analysis
. 206:s707-s708.
2025
3202 Addition of 3D-TSE Imaging into Stereotactic Radiosurgery for Brain Metastases Prolongs Time to Next Intervention
. 206:s720-s721.
2025
3208 Surgically Targeted Radiation Therapy (STaRT) vs. Post-operative Radiosurgery for Brain Metastasis
. 206:s203.
2025
3214 Evaluating the Performance of a Novel Federated AI Learning Platform in Auto-detection and Segmentation of Brain Metastases
. 206:s2515.
2025
3219 Evaluating the Performance of a Novel Federated AI Learning Platform in Auto-detection and Segmentation of Intracranial Meningiomas
. 206:s2516.
2025
344 The Neurocognitive Effects of Intracranial Progression & Subsequent Courses of Stereotactic Radiosurgery: Lessons Learned from a Prospective Registry
. 206:s650-s651.
2025
412 Proton craniospinal irradiation (pCSI) for leptomeningeal disease from solid tumors: feasibility, toxicity and clinical outcomes
. 206:s654-s655.
2025
413 Contrast-enhancing lesions induced by CNS-directed intensity modulated proton therapy: imaging characterization with relative cerebral blood volume
. 206:s655-s656.
2025
4468 Use of CBCT as a Quality Assurance Tool for Frame-Based SRS Treatments
. 206:s3703-s3704.
2025
1365: Evaluating dose parameters for cognitive decline post-radiosurgery measured by App-based assessment
. 194:s841-s842.
2024
2129: Phase 2 Trial of Stereotactic MRI-guided Adaptive Radiation Therapy in One Fraction (SMART ONE)
. 194:s1960-s1962.
2024
2130: Comparison of fractionated SRS treatment quality amongst multiple stereotactic delivery platforms
. 194:s891-s894.
2024
519: Inter-fractional glioblastoma dynamic changes observed during chemoradiotherapy with MR Linac
. 194:s756-s759.
2024
525: 18F-Fluciclovine PET/CT characterization of large BM treated with SSRS: phase 1 interim analysis
. 194:s759-s762.
2024
630: Connectome analysis & cognitive outcomes post Whole-brain RT: Prospective registry's first analysis
. 194:s769-s771.
2024
785: Machine Learning to predict time to local failure & radionecrosis post-brain metastasis radiosurgery
. 194:s794-s796.
2024
788: Limited Toxicity with Ultra-Hypofractionated MR-guided Radiotherapy for Oligometastatic Disease
. 194:s1867-s1868.
2024
Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer q
. 188.
2023
PD-0656 Evaluation of an interactive, multi-language, neurocognitive app in CNS radiation oncology
. 182:s547-s548.
2023
PD-0814 Toxicity outcomes of dose-escalated MR-guided radiation therapy for abdominal and pelvic tumors
. 182:s686-s687.
2023
PO-1670 Initial Assessment of Adaptive Pancreas SBRT Treatment Efficiency using ViewRay MRIdian A3i
. 182:s1373-s1374.
2023
PO-2023 Dosimetric Evaluation of an MR Linac System compared to multiple Stereotactic Radiotherapy systems
. 182:s1796-s1797.
2023
Developing an AI-assisted planning pipeline for hippocampal avoidance whole brain radiotherapy
. 181.
2023
Dedicated isotropic 3-D T1 SPACE sequence imaging for radiosurgery planning improves brain metastases detection and reduces the risk of intracranial relapse
. 173:84-92.
2022
OC-0928 Dedicated SRS imaging improves brain metastases detection and reduces the intracranial relapse risk
. 170:s819-s820.
2022
Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy
. 167:116-121.
2022
CT-guided versus MR-guided radiotherapy: Impact on gastrointestinal sparing in adrenal stereotactic body radiotherapy
. 166:101-109.
2022
PH-0501 Plan Adaptation in Patients with Abdominopelvic Tumors Treated with Stereotactic MR-Guided Adaptive Radiotherapy
. 161:s384.
2021
Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer
. 123:376-381.
2017
Cost-effectiveness of prophylactic cranial irradiation with hippocampal CrossMark avoidance in liMited stage small cell lung cancer
. 122:411-415.
2017
PD-0517: Memory preservation in patients with brain metastases following hippocampal avoidance whole-brain RT
. 111:s204.
2014
PO-0661: CogState computerized memory tests in patients with br ain metastases: Secondary endpoint results of RTOG 0933
. 111:s5.
2014
287 COMBINING MOLECULAR AND CLINICAL FACTORS TO PREDICT SURVIVAL OF PATIENTS WITH GLIOBLASTOMA AND VALIDATION USING RTOG 0525
. 102:s151-s152.
2012
Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy
. 100:241-246.
2011
Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: Safety profile for RTOG 0933
. 95:327-331.
2010
Comparison of linac based fractionated stereotactic radiotherapy and tornotherapy treatment plans for skull-base tumors
. 78:313-321.
2006
55 Optically guided stereotactic body radiotherapy for T3/T2 NOMO NSC-Lung Cancer
. 76:s36.
2005
Optically guided intensity modulated radiotherapy
. 61:33-44.
2001
Addition of 3D-TSE Imaging into Stereotactic Radiosurgery for Brain Metastases Prolongs Time to Next Intervention
2025
Clinical Impact of Integrating 3D-TSE Imaging into Stereotactic Radiosurgery for Brain Metastases in the Post-Whole Brain Radiotherapy Setting
2025
Contrast-enhancing lesions induced by CNS-directed intensity modulated proton therapy: imaging characterization with relative cerebral blood volume
2025
Evaluating the Performance of a Novel Federated AI Learning Platform in Auto-detection and Segmentation of Brain Metastases
2025
Evaluating the Performance of a Novel Federated AI Learning Platform in Auto-detection and Segmentation of Intracranial Meningiomas
2025
Proton craniospinal irradiation (pCSI) for leptomeningeal disease from solid tumors: feasibility, toxicity and clinical outcomes
2025
Surgically Targeted Radiation Therapy (STaRT) vs. Post-operative Radiosurgery for Brain Metastasis
2025
The Neurocognitive Effects of Intracranial Progression & Subsequent Courses of Stereotactic Radiosurgery: Lessons Learned from a Prospective Registry
2025
Use of CBCT as a Quality Assurance Tool for Frame-Based SRS Treatments
2025
Connectome analysis & cognitive outcomes post Whole-brain RT: Prospective registry's first analysis
2024
Inter-fractional glioblastoma dynamic changes observed during chemoradiotherapy with MR Linac
2024
Limited Toxicity with Ultra-Hypofractionated MR- guided Radiotherapy for Oligometastatic Disease
2024
Phase 2 Trial of Stereotactic MRI-guided Adaptive Radiation Therapy in One Fraction (SMART ONE)
2024
Dosimetric Evaluation of an MR Linac System compared to multiple Stereotactic Radiotherapy systems
2023
Evaluation of an interactive, multi-language, neurocognitive app in CNS radiation oncology
2023
Toxicity outcomes of dose-escalated MR-guided radiation therapy for abdominal and pelvic tumors
2023
Dedicated SRS imaging improves brain metastases detection and reduces the intracranial relapse risk
2022
COMBINING MOLECULAR AND CLINICAL FACTORS TO PREDICT SURVIVAL OF PATIENTS WITH GLIOBLASTOMA AND VALIDATION USING RTOG 0525
2012
DETERMINANTS OF THERAPEUTIC RESISTANCE IN GLIOBLASTOMAS: LESSONS LEARNED FROM RTOG 0211 AND BEYOND
2010
DETERMINANTS OF THERAPEUTIC RESISTANCE IN GLIOBLASTOMAS: LESSONS LEARNED FROM RTOG 0211 AND BEYOND
2010
A PROSPECTIVE RANDOMISED CONTROLLED CLINICAL TRIAL INVESTIGATING THE BENEFITS OF PATIENT-CUSTOMISED HEADRESTS VERSUS STANDARD (NON-PATIENT SPECIFIC) HEADRESTS IN THE IMMOBILISATION OF PATIENTS RECEIVING RADIOTHERAPY FOR HEAD AND NECK CANCER.
2008
AMBIGUITY IN DEFINITION OF A DOSE PAINTING TARGET
2008
BALANCING TUMOR EFFECT AND NORMAL TISSUE EFFECT IN STEREOTACTIC BODY RADIOTHERAPY (SBRT)
2008
Five years of experience with helical tomotherapy
2007
Optically guided stereotactic body radiotherapy for T1/T2 NOMO NSC-Lung cancer
2005
Delivery approaches for targets affected by breathing motion in helical tomotherapy
2004
A feasibility study on a new head and neck immobilization system
2003
Linac-based radiosurgery in the treatment of trigeminal neuralgia: a preliminary report
2003
Radiation treatment of the targets with respiratory motion using Breathing Synchronized Delivery (BSD) - A feasibility study
2003
In response to "The distribution of brain metastases in the perihippocampal region (Regarding Gondi et al., Radiother. Oncol. 2010; 95: 327-331) by van Kesteren et al
2011
Evaluation of a prospective radiation oncology departmental team review process using standardized simulation directives
2022
Assessment of extracranial metastatic disease in patients with brain metastases: How much effort is needed in the context of evolving survival prediction models?
2021
Why avoid the hippocampus? A comprehensive review
2010
Identifiers
International Standard Serial Number (ISSN)
0167-8140
Electronic International Standard Serial Number (EISSN)
1879-0887
